Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 85%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
9,174
Total Claims
$7.8M
Drug Cost
229
Beneficiaries
$34K
Cost/Patient
Risk Score Breakdown 57/100
Score components are additive. Read full methodology
Peer Comparison vs. 5,387 Infectious Disease providers
+323%
Cost per patient vs peers
$34K vs $8,010 avg
+33%
Brand preference vs peers
28.4% vs 21.3% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
7.1%
Opioid Rate
655
Opioid Claims
$141K
Opioid Cost
22.9%
Long-Acting Rate
Brand vs Generic
Brand: 2,590 claims · $7.4M
Generic: 6,534 claims · $323K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Bictegrav/Emtricit/Tenofov Ala | 383 | $1.6M |
| Somatropin | 36 | $703K |
| Tesamorelin Acetate | 92 | $672K |
| Abacavir/Dolutegravir/Lamivudi | 168 | $583K |
| Darunavir/Cob/Emtri/Tenof Alaf | 104 | $519K |
| Elviteg/Cob/Emtri/Tenof Alafen | 114 | $447K |
| Dolutegravir Sodium | 155 | $387K |
| Emtricitabine/Tenofov Alafenam | 178 | $387K |
| Emtricitab/Rilpiviri/Tenof Ala | 91 | $357K |
| Dolutegravir Sodium/Lamivudine | 106 | $303K |
| Doravirine | 113 | $210K |
| Darunavir | 95 | $199K |
| Cabotegravir/Rilpivirine | 30 | $189K |
| Darunavir/Cobicistat | 63 | $147K |
| Oxycodone Hcl | 62 | $95K |
Prescribing Profile
Patient Profile
64
Avg Age
6%
Female
2.02
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About